Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Cancer Research

• Publication date

  2014-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-14-0459PMID 25189482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significance of TP53 mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer

  2014cited by this paper
• Genomic landscape of non-small-cell lung cancer in smokers and never-smokers

  2013cited by this paper
• Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers

  2013cited by this paper
• Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities

  2012cited by this paper
• The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells.

  2012cited by this paper
• Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I

  2012cited by this paper
• Genomic landscape of non-small cell lung cancer in smokers and never-smokers.

  2012cited by this paper
• Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

  2011cited by this paper
• The Human Airway Epithelial Basal Cell Transcriptome

  2011cited by this paper
• Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

  2010cited by this paper
• Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

  2010cited by this paper
• Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

  2010influential reference
• An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

  2009cited by this paper
• Somatic mutations affect key pathways in lung adenocarcinoma

  2008cited by this paper
• Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis

  2008cited by this paper
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

  2008cited by this paper
• Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression

  2008cited by this paper
• Characterizing the cancer genome in lung adenocarcinoma

  2007cited by this paper
• Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

  2006cited by this paper
• Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

  2006cited by this paper
• A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

  2006cited by this paper
• Oncogenic pathway signatures in human cancers as a guide to targeted therapies

  2006cited by this paper
• Basaloid carcinoma of the lung: a really dismal histologic variant?

  2003cited by this paper
• Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.

  2001cited by this paper
• Estimating the number of clusters in a dataset via the gap statistic

  2000influential reference
• Basaloid bronchial carcinoma. A histologic group with a poor prognosis

  1994cited by this paper
• Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance.

  1992cited by this paper

• Aggressive basaloid squamous cell carcinoma of the lung in a young patient: a case report

  2025influential citation
• Comparison of CT findings between basaloid squamous cell carcinoma and non-basaloid squamous cell carcinoma of the lung

  2024cites this paper
• Defining the needle in a haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors.

  2024cites this paper
• Himalayan flora: targeting various molecular pathways in lung cancer

  2023cites this paper
• Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma – morphology, molecular characteristics and differential diagnosis

  2023cites this paper
• Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management.

  2023cites this paper
• CT findings of basaloid squamous cell carcinoma of the lung in 12 patients

  2022cites this paper
• Integrated molecular characterization of esophageal basaloid squamous cell carcinoma: a subtype with distinct RNA expression pattern and immune characteristics, but no specific genetic mutations

  2022cites this paper
• Liquid biopsy in lung cancer management

  2022cites this paper
• Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma

  2022cites this paper
• CT-Guided Percutaneous Core Needle Biopsy in Typing and Subtyping Lung Cancer: A Comparison to Surgery

  2022cites this paper
• miRNAs Associated with Nasopharyngeal Carcinoma: New Prognostic Biomarkers and Therapeutic Targets

  2021cites this paper
• Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer

  2021influential citation
• Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer

  2021cites this paper
• Diagnostic and management dilemma in basaloid squamous cell carcinoma of lung showing significant response to immunotherapy: Case report and literature review

  2020cites this paper
• Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics

  2020cites this paper
• Analysis of gene expression profiles of lung cancer subtypes with machine learning algorithms.

  2020cites this paper
• Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis.

  2020cites this paper
• Trends in lung cancer incidence within the last 10 years: An Eastern Anatolian single center experience

  2020cites this paper
• Classification and Imaging Findings of Lung Neoplasms.

  2020cites this paper
• Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma

  2020cites this paper
• Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis

  2019cites this paper
• Clinical characteristics and prognosis of basaloid squamous cell carcinoma of the lung: a population-based analysis

  2019cites this paper
• MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets

  2019cites this paper
• The 2015 World Health Organisation Classification of Lung Cancer

  2018cites this paper
• Lung cancer in patients with combined pulmonary fibrosis and emphysema revisited with the 2015 World Health Organization classification of lung tumors

  2018cites this paper
• Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking

  2018cites this paper
• Pulmonary Basaloid Squamous Cell Carcinoma in a Dog.

  2018cites this paper
• Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells

  2018cites this paper
• Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC

  2017cites this paper
• Correlation of clinicopathologic features and lung squamous cell carcinoma subtypes according to the 2015 WHO classification.

  2017cites this paper
• Genomic architecture of lung cancers

  2016cites this paper
• Cell adhesion and polarity in squamous cell carcinoma of the lung

  2016cites this paper
• PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome

  2016cites this paper
• Classification and Pathology of Lung Cancer.

  2016cites this paper
• Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma

  2015cites this paper
• Multi-omics Multi-scale Big Data Analytics for Cancer Genomics

  2015influential citation
• miRNA Analysis by Next-Generation Sequencing and its Prognostic Importance in Non-Small Cell Lung Cancer

  2015influential citation
• Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma.

  2015cites this paper
• The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

  2015cites this paper
• Histological diagnosis: recent developments

  2015cites this paper
• Review Article Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma

  2015cites this paper
• The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

  2015cites this paper